MARLBOROUGH, Mass. and AMSTERDAM, Aug. 27, 2023 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced positive 12-month results from the pivotal ADVENT clinical trial of the ...
As a result, and coupled with a favorable procedural workflow and procedure times, PFA is rapidly becoming incorporated into clinical practice—fast becoming the modality of choice for AF ablation in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results